Hurdles toward a cure for CML: the CML stem cell

Gallipoli, P., Abraham, S. A. and Holyoake, T. L. (2011) Hurdles toward a cure for CML: the CML stem cell. Hematology/Oncology Clinics of North America, 25(5), pp. 951-966. (doi: 10.1016/j.hoc.2011.09.001)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1016/j.hoc.2011.09.001


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Holyoake, Professor Tessa and Gallipoli, Dr Paolo and Abraham, Dr Sheela
Authors: Gallipoli, P., Abraham, S. A., and Holyoake, T. L.
Subjects:R Medicine > RB Pathology
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Hematology/Oncology Clinics of North America
Publisher:Elsevier
ISSN:0889-8588
ISSN (Online):1558-1977
Published Online:19 October 2011
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
540351The relevance of autocrine growth factor activation to the survival and proliferation of primitive chronic myeloid leukaemia (CML) cells.Paolo GallipoliMedical Research Council (MRC)G1000288Institute of Cancer Sciences